| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/08/2010 | CA2738744A1 Peptide antagonist of interleukin-15 activity |
| 04/08/2010 | CA2738650A1 Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| 04/08/2010 | CA2738583A1 Methods for the treatment of cancer |
| 04/08/2010 | CA2738563A1 8-substituted isoquinoline derivatives and the use thereof |
| 04/08/2010 | CA2737217A1 Heterocyclic jak kinase inhibitors |
| 04/08/2010 | CA2736929A1 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 04/08/2010 | CA2736429A1 Anti-notch2 antibodies and methods of use |
| 04/08/2010 | CA2736258A1 Tricyclic carbamate jak inhibitors |
| 04/08/2010 | CA2735932A1 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 04/08/2010 | CA2730261A1 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 04/08/2010 | CA2704448A1 Amorphous compositions of sunitinib base and l-malic acid |
| 04/07/2010 | EP2172559A1 Screening method |
| 04/07/2010 | EP2172488A1 Material with immunogenicity |
| 04/07/2010 | EP2172487A1 Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells |
| 04/07/2010 | EP2172483A1 ANTI-Muc17 ANTIBODY |
| 04/07/2010 | EP2172476A2 Compositions and methods for WT1 specific immunotherapy |
| 04/07/2010 | EP2172461A1 Di(arylamino)aryl compound |
| 04/07/2010 | EP2172457A2 Fredericamycin derivatives |
| 04/07/2010 | EP2172454A1 Benzimidazole derivative |
| 04/07/2010 | EP2172449A2 Process for the purification of Anastrazole |
| 04/07/2010 | EP2172246A2 Methods for Alzheimer's disease treatment and cognitive enhancement |
| 04/07/2010 | EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound |
| 04/07/2010 | EP2172219A1 Anti-cancer agent comprising an iNKT ligand and anti-PD-1 antibody or anti-PD-L1 antibody |
| 04/07/2010 | EP2172212A2 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 04/07/2010 | EP2172211A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| 04/07/2010 | EP2172198A1 p27 PROTEIN INDUCER |
| 04/07/2010 | EP2171448A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 04/07/2010 | EP2170959A1 Antibodies to human programmed death receptor pd-1 |
| 04/07/2010 | EP2170913A1 Platinum (iv) complexes |
| 04/07/2010 | EP2170899A1 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
| 04/07/2010 | EP2170894A1 Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline |
| 04/07/2010 | EP2170893A1 Heterocyclic compounds and use thereof as erk inhibitors |
| 04/07/2010 | EP2170892A2 Imidazopyrazines as protein kinase inhibitors |
| 04/07/2010 | EP2170891A1 Pyrazolopyrimidinone kinase inhibitor |
| 04/07/2010 | EP2170887A2 Heterocyclic compounds as raf kinase modulators |
| 04/07/2010 | EP2170886A1 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors |
| 04/07/2010 | EP2170885A1 Beta-carboline arylsulfonamides, method for preparing them and composition comprising them |
| 04/07/2010 | EP2170884A2 Chemical compounds |
| 04/07/2010 | EP2170882A1 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 04/07/2010 | EP2170870A1 Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
| 04/07/2010 | EP2170866A1 Phthalazine compounds, compositions and methods of use |
| 04/07/2010 | EP2170859A1 Benzimidazole amido derivatives as kinase inhibitors |
| 04/07/2010 | EP2170844A1 Novel polymorphs of erlotinib hydrochloride and method of preparation |
| 04/07/2010 | EP2170842A1 Protein kinase inhibitors and methods for using thereof |
| 04/07/2010 | EP2170839A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 04/07/2010 | EP2170834A1 Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases |
| 04/07/2010 | EP2170830A1 Compounds and methods for kinase modulation, and indications therefor |
| 04/07/2010 | EP2170827A2 Indolin-2-ones and aza-indolin-2-ones |
| 04/07/2010 | EP2170401A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 04/07/2010 | EP2170380A1 Capsid proteins and uses therefore |
| 04/07/2010 | EP2170367A2 Gbp, compositions comprising gbp, and related methods and uses thereof |
| 04/07/2010 | EP2170351A2 Methods and compositions for treatment of cancer and other angiogenesis - related diseases |
| 04/07/2010 | EP2170336A1 Method for optimizing the treatment of chronic myeloid leukemia with abl tyrosine kinase inhibitors |
| 04/07/2010 | EP2170319A2 Solubilized formulation of docetaxel without tween 80 |
| 04/07/2010 | EP2170076A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 04/07/2010 | EP2170073A1 Selective inhibitors for cyclin-dependent kinases |
| 04/07/2010 | EP2170062A1 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| 04/07/2010 | EP1590340B1 Inhibitors of histone deacetylase |
| 04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/07/2010 | EP1313499B1 Method for treating the central nervous system by administration of igf structural analogs |
| 04/07/2010 | EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN101691571A Small RNA interfering fragment of scaffold molecule 1 |
| 04/07/2010 | CN101691568A Method of producing edible immobilized active probiotics |
| 04/07/2010 | CN101691388A Method for preparing anthracycline cytotoxin compound pharmaceutically acceptable salt and application thereof |
| 04/07/2010 | CN101691384A Phosphate-containing toluylene compound, preparation method thereof and use thereof |
| 04/07/2010 | CN101691371A Pemetrexed thiocarbamide salt and preparation method thereof |
| 04/07/2010 | CN101691357A Novel disubstituted imidazolone anti-tumor compounds and preparation method thereof |
| 04/07/2010 | CN101691353A N-Boc-3,5-(E)-diarylidene-4-piperidone and application thereof in preparation of anti-tumor drugs |
| 04/07/2010 | CN101691344A Metformin acidic double salt compound and preparation method |
| 04/07/2010 | CN101690823A Method for preparing RGDV-containing cytosine arabinoside conjugate pharmacosome and application as antitumor agent |
| 04/07/2010 | CN101690820A Nano microsphere loading with platinum-containing drugs, hydrogel coated with natural polymers and preparation method and application thereof |
| 04/07/2010 | CN101690805A Preparation process of dendritic cell targeted nanoliposome tumor vaccine |
| 04/07/2010 | CN101690794A Antitumor medicament, preparation method and quality control method |
| 04/07/2010 | CN101690775A Medicament having qi-supplementing, blood-nourishing, kidney-boosting, yang-reinforcing and anti-cancer effects |
| 04/07/2010 | CN101690738A New application of harrisonia perforata and extractive thereof in preparing antitumor medicine |
| 04/07/2010 | CN101690732A Rana chensinensis egg oil health care product and preparation method thereof |
| 04/07/2010 | CN101690714A Antimicrobial, antiprotozoal and antitumor allicin liposome and preparation method thereof |
| 04/07/2010 | CN101148483B Chitosan oligosaccharide-stearic acid grafting compound modified by folic acid, preparation method and application thereof |
| 04/07/2010 | CN101088541B Medicine for treating women's tumors and malignant tumors and its prepn proces |
| 04/07/2010 | CN101045033B Ply-glycosyl modified acid-sensitive nanometer gel |
| 04/07/2010 | CN101023945B Use of non-periphery substituted phthalocyaniu metal complex |
| 04/07/2010 | CN101015698B Medicament using rare earth transferring complex compound as vector |
| 04/06/2010 | USRE41209 Platinum complexes |
| 04/06/2010 | US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 04/06/2010 | US7691992 Nucleic acids encoding the human ALEX1 protein |
| 04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
| 04/06/2010 | US7691899 non-peptide molecules, comprising side chains of amino acids, capable of adopting a helicoidal structure independent of the primary structure of the molecules; mimics active natural helices |
| 04/06/2010 | US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 04/06/2010 | US7691886 Benzimidazole derivatives as raf kinase inhibitors |
| 04/06/2010 | US7691872 Administering compound that binds human serum albumin (HSA) to increase free drug levels of the camptothecin compound during anti-topoisomerase I-based therapy in human |
| 04/06/2010 | US7691870 N-[4-(pyridine-4-yloxy)phenyl]-4-bromo-6-tefluoromethyl-1H-benzimidazole-2-carboxamide; for cancerous cell growth mediated by one or more raf-kinases |
| 04/06/2010 | US7691867 Chemical compounds |
| 04/06/2010 | US7691859 prenyl transferase inhibitors; e.g. 8-butyl-7-(3-(imidazol-5-yl)-1-oxopropyl)-2-(2-methoxyphenyl)-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine; antitumor agents; cancer of breast, colon, pancreas, prostate, lung, ovarian, epidermal; hematopoietics; Ras-dependent tumor; |
| 04/06/2010 | US7691858 3-(2,4-Diaminopteridin-6-yl)phenol or 6-(1H-Indol-4-yl)pteridine-2,4-diamine;phosphoinositide 3-kinase; enzyme inhibitors; vasculostatic agents; antiinflammatory agents; antiarthric agents; transplant rejecction; autoimmune diseases; anticarcinogenic agents |
| 04/06/2010 | US7691840 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 04/06/2010 | US7691820 Administering a 1-(4-thio-beta-D-arabinofuranosyl)- cytosine or 5- or 6-aza compound for inhibiting replication of DNA, immunomodulation and treatment of autoimmune diseases; also claimed is 1-(4-thio- beta -D-arabinofuranosyl)-5-fluorocytosine. |
| 04/06/2010 | US7691593 Regulation of lung tissue by patched therapeutics and formulations and uses related thereto |
| 04/06/2010 | US7691589 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens |
| 04/06/2010 | US7691568 Antibody composition-containing medicament |